Alnylam Pharmaceuticals
ALNY
#691
Rank
โ‚น3.549 T
Marketcap
โ‚น26,583
Share price
-2.31%
Change (1 day)
-0.02%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company